KALEE MOSES: Open Payments
NPI 1568051688 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 18 payments from 10 companies in 2025. Trend: 2023 $1,533 · 2024 $250 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Lilly USA, LLC | 3 | $53 |
| ABBVIE INC. | 2 | $45 |
| Novo Nordisk Inc | 2 | $41 |
| Exact Sciences Corporation | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Medtronic, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, MOUNJARO, VRAYLAR, The Cologuard Plus Collection Kit, REXULTI, Kerendia, INTELLIS ADAPTIVESTIM, Wegovy.
Industry payments across FL — which companies pay providers there.
